Iatrogenic arterial vasospasm during mechanical thrombectomy requiring treatment with intra‐arterial nimodipine might be associated with worse outcomes
European Journal of Neurology · 2024
DOI: 10.1111/ene.16467 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Serine Ferhat und 25 weiteren Autor:innen. Beteiligte Einrichtung: Neuroradiology Department, Bordeaux University Hospital, Bordeaux, France. Hauptthemen laut MEDLINE: Nimodipine, Iatrogenic Disease, Vasospasm, Intracranial, Vasodilator Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background and Purpose Vasospasm is a common iatrogenic event during mechanical thrombectomy (MT). In such circumstances, intra‐arterial nimodipine administration is occasionally considered. However, its use in the treatment of iatrogenic vasospasm during MT has been poorly studied. We investigated the impact of iatrogenic vasospasm treated with intra‐arterial nimodipine on outcomes after MT for large vessel occlusion stroke.
Methods
We conducted a retrospective analysis of the multicenter observational registry Endovascular Treatment in Ischemic Stroke (ETIS). Consecutive patients treated with MT between January 2015 and December 2022 were included. Patients treated with medical treatment alone, without MT, were excluded. We also excluded patients who received another in situ vasodilator molecule during the procedure. Outcomes were compared according to the occurrence of cervical and/or intracranial arterial vasospasm requiring intraoperative use of in situ nimodipine based on operator's decision, using a propensity score approach. The primary outcome was a modified Rankin Scale (mRS) score of 0–2 at 90 days. Secondary outcomes included excellent outcome (mRS score 0–1), final recanalization, mortality, intracranial hemorrhage and procedural complications. Secondary analyses were performed according to the vasospasm location (intracranial or cervical).
Results
Among 13,678 patients in the registry during the study period, 434 received intra‐arterial nimodipine for the treatment of MT‐related vasospasm. In the main analysis, comparable odds of favorable outcome were observed, whereas excellent outcome was significantly less frequent in the group with vasospasm requiring nimodipine (adjusted odds ratio [aOR] 0.78, 95% confidence interval [CI] 0.63–0.97). Perfect recanalization, defined as a final modified Thrombolysis In Cerebral Infarction score of 3 (aOR 0.63, 95% CI 0.42–0.93), was also rarer in the vasospasm group. Intracranial vasospasm treated with nimodipine was significantly associated with worse clinical outcome (aOR 0.64, 95% CI 0.45–0.92), in contrast to the cervical location (aOR 1.37, 95% CI 0.54–3.08).
Conclusion
Arterial vasospasm occurring during the MT procedure and requiring intra‐arterial nimodipine administration was associated with worse outcomes, especially in case of intracranial vasospasm. Although this study cannot formally differentiate whether the negative consequences were due to the vasospasm itself, or nimodipine administration or both, there might be an important signal toward a substantial clinical impact of iatrogenic vasospasm during MT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroradiology Department, Bordeaux University Hospital, Bordeaux, France.
- Neuroradiology Department, Toulouse University Hospital, Toulouse, France.
- Biostatistics Department, Lille University Hospital, Lille, France.
- Neurology Department, Bordeaux University Hospital, Bordeaux, France.
- Neuroradiology Department, Rothschild Foundation, Paris, France.
- Department of Interventional Neuroradiology-NEURI Brain Vascular Center, Bicêtre Hospital, APHP, Paris, France.
ORCID-Profile: Igor Sibon, Solene Moulin, Omer Eker, Wagih Ben Hassen, Bertrand Lapergue, Gaultier Marnat
Zitieren
APA
Ferhat, S., Bellanger, G., Milnerowicz, M., Kyheng, M., Labreuche, J., Sibon, I., Khobzi, M., Abousleiman, J. M., Popica, D. A., Moulin, S., Dargazanli, C., Consoli, A., Eker, O., Veunac, L., Premat, K., Gory, B., Gentric, J. C., Moreno, R., Hassen, W. B., …, & ETIS investigators (2024). Iatrogenic arterial vasospasm during mechanical thrombectomy requiring treatment with intra‐arterial nimodipine might be associated with worse outcomes. European Journal of Neurology. https://doi.org/10.1111/ene.16467
Vancouver
Ferhat S, Bellanger G, Milnerowicz M, Kyheng M, Labreuche J, Sibon I, et al. Iatrogenic arterial vasospasm during mechanical thrombectomy requiring treatment with intra‐arterial nimodipine might be associated with worse outcomes. European Journal of Neurology. 2024. doi:10.1111/ene.16467
BibTeX
@article{Ferhat2024,
author = {Ferhat, Serine and Bellanger, Guillaume and Milnerowicz, Malgorzata and Kyheng, Maeva and Labreuche, Julien and Sibon, Igor and Khobzi, Mehdi and Abousleiman, Joe-Marie and Popica, Dan-Adrian and Moulin, Solene and Dargazanli, Cyril and Consoli, Arturo and Eker, Omer and Veunac, Louis and Premat, Kevin and Gory, Benjamin and Gentric, Jean-Christophe and Moreno, Ricardo and Hassen, Wagih Ben and Gauberti, Maxime and Pop, Raoul and Rouchaud, Aymeric and Bourcier, Romain and Lapergue, Bertrand and Marnat, Gaultier and ETIS investigators, ETIS investigators},
title = {Iatrogenic arterial vasospasm during mechanical thrombectomy requiring treatment with intra‐arterial nimodipine might be associated with worse outcomes},
journal = {European Journal of Neurology},
year = {2024},
doi = {10.1111/ene.16467}
}
EUVIMED